Artificial Chordae Market Overview
The global Artificial Chordae Market was valued at USD 500 million in 2024 and is estimated at USD 500 million in 2025. The market is projected to reach USD 1.2 billion by 2035, expanding at a CAGR of 9.1% during the forecast period from 2026 to 2035.
North America is expected to remain the leading regional market, valued at USD 250 million in 2024 and projected to reach USD 580 million by 2035. Surgical sutures represented a significant material segment, valued at USD 150 million in 2024 and projected to reach USD 360 million by 2035. Polymer materials are also expected to demonstrate strong growth, reaching USD 480 million by 2035. Increasing cardiovascular disease prevalence, growing adoption of minimally invasive cardiac procedures, technological advancements, and rising healthcare expenditure are supporting market expansion.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=600825
Key Companies in the Artificial Chordae Market
Boston Scientific
CryoLife
Stryker
Cairo Healthcare
Abbott Laboratories
Athersys
Medtronic
Edwards Lifesciences
Kirkpatrick Health
Atria
LivaNova
Peters Surgical
Cardinal Health
B. Braun
Surgical Innovations
The rising prevalence of heart valve disorders is a major factor driving demand for artificial chordae solutions, particularly for mitral valve repair and reconstruction. Advancements in minimally invasive and robotic-assisted cardiac surgery are improving procedural efficiency and supporting adoption. Increasing healthcare infrastructure investments and growing awareness of heart health are also expanding access to advanced cardiovascular interventions. In addition, manufacturers are focusing on biocompatible, durable, biodegradable, and customized materials to improve patient outcomes.
Market Segmentation
The Artificial Chordae Market is segmented by Material into Surgical Suture, Polymer Materials, Metallic Materials, and Biodegradable Materials. By Application, the market includes Heart Valve Repair, Mitral Valve Reconstruction, Aortic Valve Repair, and Chordal Replacement. Based on End Use, it is divided into Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. By Technology, the market covers Artificial Chordae Loop, Pre-Fabricated Chordae, and Custom-Made Chordae. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
Recent Developments and Market Trends:
Abbott Laboratories announced a strategic partnership with CryoLife in June 2025 to jointly develop artificial chordae replacement technologies for mitral valve repair.
Edwards Lifesciences completed the acquisition of ChordArt Medical in February 2025 to accelerate artificial chordae-based solutions for surgical repair.
CryoLife launched a new artificial chordae product in April 2025 to expand minimally invasive mitral valve repair options.
Advancements in biocompatible and durable materials are supporting the development of safer artificial chordae solutions.
Customized artificial chordae designs are gaining attention as healthcare increasingly moves toward patient-specific treatment approaches.
Minimally invasive and robotic-assisted cardiac procedures are creating additional opportunities for artificial chordae technologies.
Reasons to Buy the Report:
Understand the global Artificial Chordae Market size, growth rate, and forecast through 2035.
Analyze opportunities across materials, applications, end uses, technologies, and major geographic regions.
Evaluate North America’s leading position and the growth potential of Asia Pacific.
Identify key companies and assess the competitive landscape of the artificial chordae industry.
Examine major market drivers, technological developments, and emerging trends.
Gain insights into opportunities created by minimally invasive procedures, personalized healthcare, and innovative biomaterials.
Future Outlook:
The Artificial Chordae Market is expected to experience robust growth through 2035 as cardiovascular disease prevalence increases and cardiac surgeons increasingly adopt advanced and minimally invasive repair techniques. Continued innovation in biocompatible materials, custom-made chordae, artificial chordae loops, and robotic-assisted procedures is expected to strengthen market opportunities. North America is likely to maintain its leadership, while Asia Pacific is positioned for rapid expansion as healthcare infrastructure improves and access to advanced cardiovascular treatments increases.
➤➤Explore Our Latest Related Reports:
